Table 3.
Groups | Median overall survival (months) | Median survival since the last operation (months) |
---|---|---|
Group 1 with autologous lysate (n=12) | 16 | 12 |
Group 2 with pooled lysate (n=7) | 15 | 10 |
Group 3 without immunotherapy (n=10) | 14.5 | 12 |
Groups | Median overall survival (months) | Median survival since the last operation (months) |
---|---|---|
Group 1 with autologous lysate (n=12) | 16 | 12 |
Group 2 with pooled lysate (n=7) | 15 | 10 |
Group 3 without immunotherapy (n=10) | 14.5 | 12 |